Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Yu Gan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5769-6809; OpenAlex author ID A5039589213. Sources: OpenAlex.

Their work

Papers
15 (first author 3, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 5 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 3 papers

Papers 15

  1. Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer-related gene in pancreatic cancer. Co-author DOI 10.1002/ctm2.70424↗
  2. Mendelian analysis reveals novel pancreatic cancer-associated gut bacteria with tumor-suppressive effects. Last author DOI 10.1007/s13402-025-01098-x↗
  3. Upregulation of Lactobacillus spp. in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects. Co-author DOI 10.1080/19490976.2025.2470372↗
  4. Increased Expression of Mitochondrial UQCRC1 in Pancreatic Cancer Impairs Antitumor Immunity of Natural Killer Cells via Elevating Extracellular ATP. Co-author DOI 10.3389/fonc.2022.872017↗
  5. ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway. Last author DOI 10.1038/s41420-020-00390-z↗
  6. The Application of Exosomal MicroRNAs in the Treatment of Pancreatic Cancer and Its Research Progress. Co-author DOI 10.1097/mpa.0000000000001713↗
  7. Shedding Light on the Role of Neurotransmitters in the Microenvironment of Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.688953↗
  8. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Last author DOI 10.3389/fonc.2021.634167↗
  9. Corrigendum: E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer via Destabilizing F-Actin Capping Protein CAPZA1. Last author DOI 10.3389/fonc.2021.693855↗
  10. Cadherin 13 Inhibits Pancreatic Cancer Progression and Epithelial-mesenchymal Transition by Wnt/β-Catenin Signaling. Co-author DOI 10.7150/jca.37762↗
  11. Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.7150/thno.38704↗
  12. Adiponectin Suppresses Human Pancreatic Cancer Growth through Attenuating the β-Catenin Signaling Pathway. Last author DOI 10.7150/ijbs.27420↗
  13. Enriched environment housing enhances the sensitivity of mouse pancreatic cancer to chemotherapeutic agents. First author DOI 10.1016/j.bbrc.2016.03.128↗
  14. Enriched environment inhibits mouse pancreatic cancer growth and down-regulates the expression of mitochondria-related genes in cancer cells. First author DOI 10.1038/srep07856↗
  15. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production. First author DOI 10.18632/oncotarget.3878↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hong Tu · 14 shared papers, 2015–2025 · strength 1.85
  2. Jin Li · 5 shared papers, 2021–2025 · strength 0.78
  3. Hui Cong · 5 shared papers, 2021–2025 · strength 0.78
  4. Yiyi Liang · 5 shared papers, 2021–2025 · strength 0.77
  5. Mengge Li · 5 shared papers, 2020–2025 · strength 0.64
  6. Yingchao Fan · 5 shared papers, 2015–2020 · strength 0.35
  7. Weidong Zhang · 1 shared paper, 2025 · strength 0.30
  8. Yi Tong · 1 shared paper, 2025 · strength 0.30
  9. Dengfei Xu · 2 shared papers, 2020–2021 · strength 0.23
  10. Yuan Fang · 2 shared papers, 2021 · strength 0.22
  11. Liwei Wang · 1 shared paper, 2025 · strength 0.21
  12. Jiujie Cui · 1 shared paper, 2025 · strength 0.21
  13. Zhigang Zhang · 2 shared papers, 2020 · strength 0.21
  14. Yongwei Sun · 1 shared paper, 2025 · strength 0.20
  15. Dejun Liu · 1 shared paper, 2025 · strength 0.20
  16. Wence Zhou · 1 shared paper, 2021 · strength 0.19
  17. Wenkai Jiang · 1 shared paper, 2021 · strength 0.19
  18. Xin Li · 1 shared paper, 2021 · strength 0.19
  19. Chunmei Yang · 1 shared paper, 2021 · strength 0.12
  20. Yufeng Wu · 2 shared papers, 2015–2016 · strength 0.10
  21. Jinghui Jiang · 1 shared paper, 2019 · strength 0.10
  22. Qing Wang · 1 shared paper, 2020 · strength 0.10
  23. Shu‐Heng Jiang · 1 shared paper, 2020 · strength 0.10
  24. Jian Zhang · 1 shared paper, 2016 · strength 0.06
  25. Fangyu Zhao · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.